Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
Journal of the American Academy of Dermatology
|
September 15, 2019
Thiazides and nonmelanoma skin cancer: Is it a class effect?
Xavier Humbert, Charles Dolladille, Basile Chrétien, et al.
Plos One
|
March 7, 2025
Hypertension associated with serotonin reuptake inhibitors: A new analysis in the WHO pharmacovigilance database and examination of dose-dependency
Basile Chrétien, Andry Rabiaza, Nishida Kazuki, et al.
Melanoma Research
|
February 23, 2023
Recurrent hemophagocytic lymphohistiocytosis in advanced melanoma treated with two different BRAF/MEK-inhibitor regimens
Jean-Baptiste Le Goubey, Marion Sassier, Ines Nakouri, et al.
Cardiovascular Drugs and Therapy
|
April 28, 2023
Rhabdomyolysis with Co-Administration of Statins and Antiplatelet Therapies-Analysis of the WHO Pharmacovigilance Database
Vincent Roule, Joachim Alexandre, Adrien Lemaitre, et al.
Therapie
|
January 24, 2025
BRAF and MEK inhibitors rechallenge after an adverse drug reaction in patients with cancer: A pharmacovigilance cohort study
Emilien Ezine, Angélique Da Silva, Safa Idoudi, et al.
Therapie
|
April 10, 2021
Characteristics of insulinopenic and non insulinopenic diabetes related to immune checkpoint inhibitors: A French pharmacovigilance study
Marie Bastin, Marion Allouchery, Marion Sassier, et al.
Frontiers in Pharmacology
|
October 18, 2023
Infections associated with clozapine: a pharmacovigilance study using VigiBase<sup>®</sup>
Basile Chrétien, Perrine Brazo, Angélique Da Silva, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 5, 2016
Successful treatment with ceritinib after crizotinib induced hepatitis
Marion Sassier, Bertrand Mennecier, Anthony Gschwend, et al.
Therapie
|
December 30, 2020
[Adverse drug reactions profiles for abiraterone and enzalutamide: A pharmacovigilance descriptive analysis]
Lucie-Marie Scailteux, Clémence Lacroix, Sandrine Bergeron, et al.
Scientific Reports
|
December 21, 2019
Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance database
Julie Garon-Czmil, Nadine Petitpain, Franck Rouby, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
Journal of the American Academy of Dermatology
|
September 15, 2019
Thiazides and nonmelanoma skin cancer: Is it a class effect?
Xavier Humbert, Charles Dolladille, Basile Chrétien, et al.
Plos One
|
March 7, 2025
Hypertension associated with serotonin reuptake inhibitors: A new analysis in the WHO pharmacovigilance database and examination of dose-dependency
Basile Chrétien, Andry Rabiaza, Nishida Kazuki, et al.
Melanoma Research
|
February 23, 2023
Recurrent hemophagocytic lymphohistiocytosis in advanced melanoma treated with two different BRAF/MEK-inhibitor regimens
Jean-Baptiste Le Goubey, Marion Sassier, Ines Nakouri, et al.
Cardiovascular Drugs and Therapy
|
April 28, 2023
Rhabdomyolysis with Co-Administration of Statins and Antiplatelet Therapies-Analysis of the WHO Pharmacovigilance Database
Vincent Roule, Joachim Alexandre, Adrien Lemaitre, et al.
Therapie
|
January 24, 2025
BRAF and MEK inhibitors rechallenge after an adverse drug reaction in patients with cancer: A pharmacovigilance cohort study
Emilien Ezine, Angélique Da Silva, Safa Idoudi, et al.
Therapie
|
April 10, 2021
Characteristics of insulinopenic and non insulinopenic diabetes related to immune checkpoint inhibitors: A French pharmacovigilance study
Marie Bastin, Marion Allouchery, Marion Sassier, et al.
Frontiers in Pharmacology
|
October 18, 2023
Infections associated with clozapine: a pharmacovigilance study using VigiBase<sup>®</sup>
Basile Chrétien, Perrine Brazo, Angélique Da Silva, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 5, 2016
Successful treatment with ceritinib after crizotinib induced hepatitis
Marion Sassier, Bertrand Mennecier, Anthony Gschwend, et al.
Therapie
|
December 30, 2020
[Adverse drug reactions profiles for abiraterone and enzalutamide: A pharmacovigilance descriptive analysis]
Lucie-Marie Scailteux, Clémence Lacroix, Sandrine Bergeron, et al.
Scientific Reports
|
December 21, 2019
Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance database
Julie Garon-Czmil, Nadine Petitpain, Franck Rouby, et al.
Page
of 5